The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic VirusesArticle Published on 2022-09-122022-11-15 Journal: Molecules [Category] [DOI] 10.3390/molecules27185928 PMC 바로가기
2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trialClinical Trial Published on 2022-08-042022-10-04 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-022-07642-6 PMC 바로가기 [Article Type] Clinical Trial
A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19Research article Published on 2022-05-112022-10-05 Journal: Heliyon [Category] [DOI] 10.1016/j.heliyon.2022.e09387 [Article Type] Research article
Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions해당 억제제 2-deoxy-d-glucose는 숙주 세포에서 SARS-CoV-2 증식을 약화시키고 자손 비리온의 감염 가능성을 약화시킵니다Article Published on 2022-04-152022-09-11 Journal: Life sciences [Category] [DOI] 10.1016/j.lfs.2022.120411 PMC 바로가기 [Article Type] Article
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1Immunology Published on 2021-11-112022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2021.733921 PMC 바로가기 [Article Type] Immunology
AMPK and Akt/mTOR signalling pathways participate in glucose-mediated regulation of hepatitis B virus replication and cellular autophagyArticle Published on 2020-02-012023-06-12 Journal: Cellular microbiology [Category] [DOI] 10.1111/cmi.13131 PMC 바로가기